NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Appropriations | ₹480 Cr | ₹445 Cr | ₹409 Cr | ₹378 Cr | ₹26 Cr |
What is the latest Appropriations of NATH BIOGENES (INDIA) ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹480 Cr |
| Mar2024 | ₹445 Cr |
| Mar2023 | ₹409 Cr |
| Mar2022 | ₹378 Cr |
| Mar2013 | ₹26 Cr |
How is Appropriations of NATH BIOGENES (INDIA) Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹480 Cr | 7.82 | |
| Mar2024 | ₹445 Cr | 8.75 | |
| Mar2023 | ₹409 Cr | 8.26 | |
| Mar2022 | ₹378 Cr | 1,362.61 | |
| Mar2013 | ₹26 Cr | - | |
Compare Appropriations of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹242.5 Cr | -5.3% | -14.5% | -16.9% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹9,215.1 Cr | -5.3% | -25% | -24.9% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,018.7 Cr | -0.5% | -2.9% | -41.9% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,650.5 Cr | -4.1% | -14% | -29.2% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹637.0 Cr | -20.6% | -32.5% | -46.6% | Stock Analytics | |
| INDO US BIOTECH | ₹196.3 Cr | -3.5% | -28.3% | -39.2% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -5.3% |
-14.5% |
-16.9% |
| SENSEX | -3.5% |
-12.5% |
-6.5% |
You may also like the below Video Courses